Zobrazeno 1 - 10
of 492
pro vyhledávání: '"Marisa Moore"'
Autor:
Emily Han, Scott A. Nabity, Shom Dasgupta-Tsinikas, Ramon E. Guevara, Marisa Moore, Ankita Kadakia, Hannah Henry, Martin Cilnis, Sonal Buhain, Amit Chitnis, Melony Chakrabarty, Ann Ky, Quy Nguyen, Julie Low, Seema Jain, Julie Higashi, Pennan M. Barry, Jennifer Flood
Publikováno v:
Emerging Infectious Diseases, Vol 30, Iss 1, Pp 136-140 (2024)
We assessed tuberculosis (TB) diagnostic delays among patients with TB and COVID-19 in California, USA. Among 58 persons, 43% experienced TB diagnostic delays, and a high proportion (83%) required hospitalization for TB. Even when viral respiratory p
Externí odkaz:
https://doaj.org/article/35a113516ea246f59964e1ba6b1a1c53
Autor:
PR Newswire
Publikováno v:
PR Newswire US. 05/20/2022.
Autor:
Annie Belanger, Sapna Bamrah Morris, Richard Brostrom, David Yost, Neela Goswami, Margaret Oxtoby, Marisa Moore, Janice Westenhouse, Pennan M. Barry, Neha S. Shah
Publikováno v:
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 15, Iss , Pp - (2019)
The current tuberculosis (TB) case reporting system for the United States, the Report of Verified Case of TB (RVCT), has minimal capture of multidrug-resistant (MDR) TB treatment and adverse events. Data were abstracted in five states using the form
Externí odkaz:
https://doaj.org/article/d67f3477e1f44627a12f259555d5eaf4
Autor:
Apel, Marisa Moore
Publikováno v:
University of Cincinnati Law Review; Dec2021, Vol. 90 Issue 2, p688-710, 23p
Publikováno v:
Atlanta Tribune; Oct2018, Vol. 32 Issue 6, p19-19, 1p
Autor:
Timothy C. Rodwell, Marisa Moore, Kathleen S. Moser, Stephanie K. Brodine, Steffanie A. Strathdee
Publikováno v:
Emerging Infectious Diseases, Vol 14, Iss 6, Pp 909-916 (2008)
The epidemiology of tuberculosis (TB) in the United States is changing as the incidence of disease becomes more concentrated in foreign-born persons. Mycobacterium bovis appears to be contributing substantially to the TB incidence in some binational
Externí odkaz:
https://doaj.org/article/f67a1d41c76c4002a99a9f4a77ee96dc
Autor:
Christine S Ho, Pei-Jean I Feng, Masahiro Narita, Jason E Stout, Michael Chen, Lisa Pascopella, Richard Garfein, Randall Reves, Dolly J Katz, Jennifer Flood, Julie Higashi, Kathleen Moser, Marisa Moore, Constance Benson, Robert Belknap, Jason E. Stout, Amina Ahmed, Timothy Sterling, April Pettit, Henry M. Blumberg, Alawode Oladele, Michael Lauzardo, Marie N. Seraphin, Richard Brostrom, Renuka Khurana, Wendy Cronin, Susan Dorman, David Horne, Thaddeus Miller
Publikováno v:
Lancet Infect Dis
BACKGROUND: Treatment of latent tuberculosis infection is an important strategy to prevent tuberculosis disease. In the USA, three tests are used to identify latent tuberculosis infection: the tuberculin skin test (TST) and two IFN-γ release assays
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08e933412283cfc14021bf1b6a2b52ce
https://europepmc.org/articles/PMC8712384/
https://europepmc.org/articles/PMC8712384/
Autor:
Deborah S. Yokoe, Steven W. Coon, Rachel Dokholyan, Michael C. Iannuzzi, Timothy F. Jones, Sarah Meredith, Marisa Moore, Lynelle Phillips, Wayne Ray, Stephanie Schech, Deborah Shatin, Richard Platt
Publikováno v:
Emerging Infectious Diseases, Vol 10, Iss 8, Pp 1426-1431 (2004)
Underreporting tuberculosis (TB) cases can compromise surveillance. We evaluated the contribution of pharmacy data in three different managed-care settings and geographic areas. Persons with more than two anti-TB medications were identified by using
Externí odkaz:
https://doaj.org/article/54588fe13a6c43e491cabf95e08ee3f2
Autor:
Barbara A. Ellis, Jack T. Crawford, Christopher R. Braden, Scott J. N. McNabb, Marisa Moore, Steve Kammerer
Publikováno v:
Emerging Infectious Diseases, Vol 8, Iss 11, Pp 1197-1209 (2002)
We conducted a population-based study to assess demographic and risk-factor correlates for the most frequently occurring Mycobacterium tuberculosis genotypes from tuberculosis (TB) patients. The study included all incident, culture-positive TB patien
Externí odkaz:
https://doaj.org/article/a659ea0365ad44c4969312dac5339e42
Autor:
Neha Shah, Neela D Goswami, Richard Brostrom, David Yost, Margaret J. Oxtoby, Pennan M. Barry, Annie Belanger, Janice Westenhouse, Sapna Bamrah Morris, Marisa Moore
Publikováno v:
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 15, Iss, Pp-(2019)
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
The current tuberculosis (TB) case reporting system for the United States, the Report of Verified Case of TB (RVCT), has minimal capture of multidrug-resistant (MDR) TB treatment and adverse events. Data were abstracted in five states using the form